TSLA
Tesla
-- 436.170 MU
Micron Technology
-- 87.090 NVDA
NVIDIA
-- 130.680 QUBT
Quantum Computing
-- 15.140 NUKK
Nukkleus
-- 52.100 
$Aprea Therapeutics (APRE.US)$ NEWS Aprea Therapeutics Annou...
NEWS
Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
Aprea Therapeutics, Inc. announces positive pre-clinical findings for APR-1051, a WEE1 kinase inhibitor, indicating potential as a treatment for Cyclin E-overexpressing cancers. The company also received IND clearance for APR-1051 and presented details on the planned Phase 1 trial. ATRN-119, a novel ATR inhibitor, shows promising safety and tolerability in an ongoing study with preliminary signs of clinical benefit.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment